Myriad Genetics (MYGN) Gains from Investment Securities (2009 - 2026)
Myriad Genetics (MYGN) reported Gains from Investment Securities of $100000.0 for Q1 2026, up 120.0% year-over-year from $45454.5 in Q1 2025, and down 91.67% quarter-over-quarter from $1.2 million in Q4 2025.
Myriad Genetics (MYGN) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of Gains from Investment Securities data on file, last reported at $100000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $100000.0, up 120.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (up 1416.67% YoY), and the FY2025 annual result was $7.3 million, changed N/A from the prior year.
- Gains from Investment Securities declined to $100000.0 in Q1 2026 per MYGN's latest filing, from $1.2 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $12.0 million in Q3 2024 and troughed at -$12.2 million in Q4 2024.
- A 5-year average of $400000.0 and a median of $200000.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities sank 1425.0% in 2024, then jumped 600.0% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$9.1 million in 2022, then soared by 91.21% to -$800000.0 in 2023, then slumped by 1425.0% to -$12.2 million in 2024, then jumped by 109.84% to $1.2 million in 2025, then plunged by 91.67% to $100000.0 in 2026.
- Business Quant data shows MYGN's Gains from Investment Securities at $100000.0 in Q1 2026, $1.2 million in Q4 2025, and $5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 1.20 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Jun 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | -12.20 Mn |
| Dec 31, 2024 | -12.20 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | -800,000.00 |
| Dec 31, 2023 | -800,000.00 |